| A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia (NCT00048035) | Hoffmann-La Roche | 2002-03-01 |
| A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. (NCT00048048) | Hoffmann-La Roche | 2002-03-01 |
| A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer (NCT02748213) | Hoffmann-La Roche | 2002-02-01 |
| Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B (NCT00048945) | Hoffmann-La Roche | 2002-01-01 |
| Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus (NCT00057317) | Hoffmann-La Roche | 2001-12-01 |
| A Study of Mircera in Anemic Patients With Multiple Myeloma (NCT00360347) | Hoffmann-La Roche | 2001-11-29 |
| Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer (NCT00045032) | Hoffmann-La Roche | 2001-11-01 |
| A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD) (NCT02617784) | Hoffmann-La Roche | 2001-10-01 |
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer (NCT00048139) | Hoffmann-La Roche | 2001-10-01 |
| A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. (NCT00364832) | Hoffmann-La Roche | 2001-10-01 |
| T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents (NCT00022763) | Hoffmann-La Roche | 2001-08-01 |
| A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer (NCT02015676) | Hoffmann-La Roche | 2001-07-01 |
| A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer (NCT00048126) | Hoffmann-La Roche | 2001-07-01 |
| Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer (NCT00022698) | Hoffmann-La Roche | 2001-05-01 |
| A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid Arthritis (NCT02693210) | Hoffmann-La Roche | 2001-02-01 |
| A Study of RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4 (NCT00869661) | Hoffmann-La Roche | 2001-02-01 |
| An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection (NCT01902615) | Hoffmann-La Roche | 2001-01-01 |
| A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer (NCT02013765) | Hoffmann-La Roche | 2001-01-01 |
| A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer (NCT00022672) | Hoffmann-La Roche | 2001-01-01 |
| A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer (NCT02006667) | Hoffmann-La Roche | 2001-01-01 |
| A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients (NCT00048152) | Hoffmann-La Roche | 2000-12-01 |
| A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia (NCT00321919) | Hoffmann-La Roche | 2000-07-01 |
| Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs) (NCT02784808) | Hoffmann-La Roche | 2000-01-01 |
| A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients (NCT00002448) | Hoffmann-La Roche | 1999-10-01 |
| A Study to Compare Two Anti-HIV Drug Combinations (NCT00002447) | Hoffmann-La Roche | 1999-10-01 |
| A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation (NCT00048165) | Hoffmann-La Roche | 1999-08-01 |
| A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer (NCT02721641) | Hoffmann-La Roche | 1999-06-01 |
| A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults (NCT00002239) | Hoffmann-La Roche | 1999-05-01 |
| A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer (NCT00009737) | Hoffmann-La Roche | 1998-11-01 |
| A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma (NCT01388959) | Hoffmann-La Roche | 1998-11-01 |
| A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma (NCT00269113) | Hoffmann-La Roche | 1998-09-01 |
| Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer (NCT00005649) | Hoffmann-La Roche | 1998-07-01 |
| A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma (NCT01392716) | Hoffmann-La Roche | 1997-10-01 |
| A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma (NCT01998893) | Hoffmann-La Roche | 1997-01-01 |
| A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes (NCT00002377) | Hoffmann-La Roche | 1997-01-01 |
| A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir (NCT00002251) | Hoffmann-La Roche | |
| A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs (NCT00002162) | Hoffmann-La Roche | |
| A Study of NeoRecormon in Patients With Chronic Kidney Disease. (NCT00437723) | Hoffmann-La Roche | |
| A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS (NCT00002273) | Hoffmann-La Roche | |
| The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children (NCT00002380) | Hoffmann-La Roche | |
| An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies (NCT00002118) | Hoffmann-La Roche | |
| A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis. (NCT00365001) | Hoffmann-La Roche | |
| A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients (NCT00002178) | Hoffmann-La Roche | |
| A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients (NCT00002190) | Hoffmann-La Roche | |
| An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access (NCT00002135) | Hoffmann-La Roche | |
| The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs (NCT00002425) | Hoffmann-La Roche | |
| The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002299) | Hoffmann-La Roche | |
| A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection (NCT00002117) | Hoffmann-La Roche | |
| A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS (NCT00002257) | Hoffmann-La Roche | |
| A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients (NCT00002383) | Hoffmann-La Roche | |
| A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS (NCT00002034) | Hoffmann-La Roche | |
| Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions (NCT03066661) | Hoffmann-La Roche | |
| A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease (NCT00002397) | Hoffmann-La Roche | |
| A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma (NCT00002314) | Hoffmann-La Roche | |
| Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients (NCT00002229) | Hoffmann-La Roche | |
| A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia. (NCT00440063) | Hoffmann-La Roche | |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00106548) | Hoffmann-La Roche | |
| A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus (NCT00002095) | Hoffmann-La Roche | |
| T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs (NCT00021554) | Hoffmann-La Roche | |
| Expanded Access to RXDX-105 for Cancers With RET Alterations (NCT03052569) | Hoffmann-La Roche | |
| A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS (NCT00002222) | Hoffmann-La Roche | |
| A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment (NCT00002334) | Hoffmann-La Roche | |
| A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. (NCT00545207) | Hoffmann-La Roche | |
| Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC (NCT00001040) | Hoffmann-La Roche | |
| A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients (NCT00002374) | Hoffmann-La Roche | |
| A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine (NCT00002096) | Hoffmann-La Roche | |
| An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492 (NCT00002265) | Hoffmann-La Roche | |
| T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs (NCT00008528) | Hoffmann-La Roche | |
| A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease. (NCT00413101) | Hoffmann-La Roche | |
| Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections (NCT00002024) | Hoffmann-La Roche | |
| A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00002367) | Hoffmann-La Roche | |
| Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection (NCT00017784) | Hoffmann-La Roche | |
| A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients (NCT00002382) | Hoffmann-La Roche | |
| An Observational Study on Long-Term Effectiveness and Safety of RoActemra/Actemra (Tocilizumab) in Daily Practice in Patients With Rheumatoid Arthritis (ICHIBAN) (NCT01194401) | Hoffmann-La Roche | |
| Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient (NCT00002025) | Hoffmann-La Roche | |
| A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients (NCT00002378) | Hoffmann-La Roche | |
| A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine (NCT00002333) | Hoffmann-La Roche | |
| Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease (NCT00002081) | Hoffmann-La Roche | |
| Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy. (NCT00002256) | Hoffmann-La Roche | |
| A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy (NCT00002247) | Hoffmann-La Roche | |
| A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT) (NCT00002279) | Hoffmann-La Roche | |
| Treatment of Psoriasis Using Acitretin in HIV-Positive Patients (NCT00002143) | Hoffmann-La Roche | |